Agar sublimation test for the in vitro determination of the antifungal activity of morpholine derivatives

被引:15
作者
Polak, A
Jäckel, A
Noack, A
Kappe, R
机构
[1] Spitzrainweg, Aesch, Switzerland
[2] Galderma Lab GmbH, Dept Med, Freiburg, Germany
[3] Haema AG, Inst Med Microbiol, Erfurt, Germany
[4] Helios Med Ctr, Erfurt, Germany
关键词
antifungal activity; morpholine; sublimation;
D O I
10.1111/j.1439-0507.2004.00975.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We studied the in vitro antifungal activities of a wide range of antimycotic agents, including amorolfine, terbinafine, naftifine, five morpholine derivatives, ciclopiroxolamine, bifonazole, clotrimazole, ketoconazole, itraconazole, fluconazole, voriconazole, flucytosine, amphotericin B, nystatin, and caspofungin, against Candida albicans and Trichophyton rubrum by conventional agar diffusion tests and by a novel sublimation method. For the sublimation method, 6 mm filter paper disks were soaked with defined amounts of antimycotic drugs, air dried, placed in the center of the lids of 9 cm Petri dishes, and incubated upside down with inoculated agar plates 10 mm above the disks. The conventional disk diffusion tests produced inhibition zones as previously described. The disk sublimation tests produced large inhibition zones with amorolfine, five amorolfine derivatives, and terbinafine, but with none of the other antifungal agents. Possible therapeutic advantages of agents, which are able to overcome air cavities in mycotic lesions, e.g. in onychomycosis, are discussed.
引用
收藏
页码:184 / 192
页数:9
相关论文
共 15 条
[1]   A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region [J].
Baran, R ;
Feuilhade, M ;
Datry, A ;
Goettmann, S ;
Pietrini, P ;
Viguie, C ;
Badillet, G ;
Larnier, C ;
Czernielewski, J .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (06) :1177-1183
[2]  
Effendy I., 1999, Mycoses, V42, P172
[3]  
Grimmer H., 1962, GRISEOFULVINBEHANDLU, P74, DOI [10.1007/978-3-642-86275-5.pdf#page=79, DOI 10.1007/978-3-642-86275-5.PDF#PAGE=79]
[4]  
Isenring H. P., 1987, Recent trends in the discovery, development and evaluation of antifungal agents., P543
[5]  
Lecha M, 2001, BRIT J DERMATOL, V145, P21, DOI 10.1046/j.1365-2133.2001.145s60021.x
[6]   DETERMINATION OF THE SUBUNGUAL ANTIFUNGAL ACTIVITY OF AMOROLFINE AFTER 1 MONTHS TREATMENT IN PATIENTS WITH ONYCHOMYCOSIS - COMPARISON OF 2 NAIL LACQUER FORMULATIONS [J].
MENSING, H ;
POLAKWYSS, A ;
SPLANEMANN, V .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1992, 17 :29-32
[7]  
NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS-NCCLS, 1997, M27A NCCLS
[8]   Combination therapy for onychomycosis [J].
Olafsson, JH ;
Sigurgeirsson, B ;
Baran, R .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 :15-18
[9]  
Polak A., 1987, Recent trends in the discovery, development and evaluation of antifungal agents., P555
[10]  
POLAK A, 1993, MYCOSES, V36, P101, DOI 10.1111/j.1439-0507.1993.tb00696.x